LEHI, UT –October 6, 2025– Lumea, a leader in digital pathology solutions, has been named the Healthcare Tech Innovator of the Year 2025 – Western USA and the Leading Provider of Digital Pathology Solutions 2025 by Global Health & Pharma (GHP) Magazine’s Healthcare and Pharmaceutical Awards. These two prestigious awards recognize Lumea’s profound commitment to advancing cancer diagnostics through effective, workflow-driven technology.
The GHP Healthcare and Pharmaceutical Awards, now in its tenth year, celebrates the businesses and innovators that are revolutionizing the healthcare and pharmaceutical industries. From groundbreaking medical research to life-saving treatments and cutting-edge technology, the awards shine a spotlight on those making a tangible impact on global health and well-being.
Awards Coordinator Melissa Bramall of GHP Magazine was delighted to be part of the process, stating: “Connecting with the winners of our tenth edition of this esteemed awards programme has been a fantastic experience, as I’m happy to congratulate them for their dedication and success. We work diligently to recognise and applaud the businesses and individuals across the all important sectors within the healthcare and pharmaceutical arenas, and it’s an honour to be part of their journeys.”
Covering success stories across a diverse industry (from nursing and medical administration to social and domiciliary care, and more), the 2025 program endeavors to recognize those who are going above and beyond or leading the industry forward. Lumea’s dual recognition underscores its leadership and innovation within the rapidly evolving digital health sector.
“These awards are a tremendous honor and validate our team’s relentless pursuit of excellence in digital pathology,” said James Thackeray, CEO of Lumea. “Being named Healthcare Tech Innovator of the Year and Leading Provider of Digital Pathology Solutions highlights our role in transforming diagnostics to be more precise and efficient. We are proud to be at the forefront of this movement, bringing simplified, workflow-driven innovation to pathology practices across the globe.”
Lumea was selected for its comprehensive approach to digital pathology, from its proprietary tissue-handling technology to its AI-driven viewer. This end-to-end solution optimizes tissue integrity, enhances detection rates, and improves patient outcomes.
About Lumea
Lumea is powering efficient, affordable, and accessible digital pathology through simplified, workflow-driven innovation with both tissue-handling technology and a best-in-class viewer with AI-driven workflows. As the U.S. leader in primary clinical digital pathology, processing the highest volume of digital cases nationwide. With over a decade of expertise, Lumea has set the standard for efficiency, quality, and premium cancer diagnostics. With a global presence spanning five continents, Lumea supports over half of the U.S. urology market and top dermatology and gastroenterology groups, optimizing tissue integrity, boosting detection rates, and delivering measurable ROI. By placing patients at the core, Lumea is transforming pathology for a more precise and efficient future. Learn more at https://lumeadigital.com.
About Global Health & Pharma
Global Health & Pharma (GHP) is a trusted source of news, features, and in-depth analysis on the latest trends and developments in the healthcare and pharmaceutical industries. GHP’s Healthcare and Pharmaceutical Awards celebrate companies and innovators that are revolutionizing the industry through groundbreaking medical research and cutting-edge technology, making a tangible impact on global health and well-being.
